KRAS and familial pancreatic carcinoma: Our results showed that K-Ras upregulated miR-155 expression through MAPK and NF-κB pathway and miR-155 promoted pancreatic cancer cell proliferation by increase of ROS levels through inhibiting Foxo3a expression.